New distribution! Reach relevant USA TODAY Network news sites. Get started ›

New distribution! Reach relevant USA TODAY Network news sites. Get started ›

World Media Directory · RSS · Email Newsletters

There were 507 press releases posted in the last 24 hours and 468,833 in the last 365 days.

Press Releases on January 26, 2024

1,046 Press Releases

Published on January 26, 2024 - 14:30 GMT

1, 4 Butanediol Market Size, Share And Growth Analysis For 2024-2033

The Business Research Company's 1, 4 Butanediol Global Market Report 2024– Market Size, Trends, And Global Forecast 2024-2033 LONDON, GREATER LONDON, UK, January 26, 2024 /⁨EINPresswire.com⁩/ -- The Business Research Company has updated its global …

Distribution channels: Business & Economy, Chemical Industry ...
Published on January 26, 2024 - 14:29 GMT

Human medicines European public assessment report (EPAR): Ryzneuta, efbemalenograstim alfa, Status: Opinion

Overview On 25 January 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Ryzneuta, intended to reduce the duration of neutropenia and …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:29 GMT

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Assertio Holdings, Inc. of Class ...

NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT). The class action, filed in the United States District Court for …

Distribution channels: Consumer Goods, Law ...
Published on January 26, 2024 - 14:28 GMT

Human medicines European public assessment report (EPAR): Aerinaze, desloratadine,pseudoephedrine, Date of authorisation: 30/07/...

Aerinaze contains two active substances: desloratadine, an antihistamine, and pseudoephedrine, which is a nasal decongestant. Desloratadine works by blocking the receptors on which histamine, a substance in the body that causes allergic symptoms, normally …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

Human medicines European public assessment report (EPAR): Nezglyal, leriglitazone, Status: Opinion

The active substance in Nezglyal, leriglitazone, works by attaching to and activating receptors (targets) called 'PPAR gamma receptors', which are found inside cells, including nerve cells. PPAR gamma receptors play a role in regulating the …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

EMA confirms measures to minimise the risk of serious side effects with medicines containing pseudoephedrine

PRES and RCVS are rare conditions that can involve reduced blood supply to the brain, potentially causing serious, life-threatening complications. With prompt diagnosis and treatment, symptoms of PRES and RCVS usually resolve. CHMP confirmed that …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

Human medicines European public assessment report (EPAR): Exblifep, cefepime,enmetazobactam, Status: Opinion

Overview On 25 January 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Exblifep, intended for the treatment of urinary tract …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

Orphan designation: 5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride Treatment of ...

Adrenoleukodystrophy (ALD) is an inherited disease in which there is a build-up of fatty substances known as 'very long chain fatty acids' (VLCFAs) in tissues around the body, mainly in the brain and spinal cord and in the adrenal glands, the small …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

Human medicines European public assessment report (EPAR): Niapelf, paliperidone, Status: Opinion

Overview On 25 January 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Niapelf, intended for the treatment of schizophrenia. The …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

Precautionary measures to address potential risk of neurodevelopmental disorders in children born to men treated with valproate ...

On 24 January 2024, the CMDh1 endorsed precautionary measures recommended by EMA’s safety committee (PRAC) for the treatment of male patients with valproate medicines. These measures are to address a potential increased risk of neurodevelopmental disorders …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

Plasmid DNA vaccines for veterinary use – Scientific guideline

This document addresses the quality, safety and efficacy aspects of nucleic acid vaccines for use in animals. It is applicable to vaccines consisting of plasmid DNA, non-amplifiable in eukaryotic cells. Keywords: plasmid DNA vaccines, vaccines for …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

Live recombinant vector vaccines for veterinary use - Scientific guideline

This guidelines provides guidance on the data to be submitted in the marketing authorisation application for the veterinary live recombinant vector vaccines. Keywords: Live, recombinant vector vaccine, veterinary

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

Committee for Herbal Medicinal Products (HMPC): 29-31 January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 29 ...

Agenda of the HMPC meeting 29-31 January 2024 DraftFirst published: 26/01/2024Reference Number: EMA/HMPC/572004/2023

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

Maximum residue limit (MRL) evaluation for biological substances - Scientific guideline

This concept paper addresses the need for a guideline on determination of the need for an MRL evaluation for biological substances, when it is intended that those substances are included in products for use in food-producing species. Keywords: biological …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

Committee for Advanced Therapies (CAT): 6-8 December 2023, European Medicines Agency, Amsterdam, the Netherlands, from 6 December ...

The Committee for Advanced Therapies (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on January 26, 2024 - 14:28 GMT

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investments in General Motors Company of Class ...

NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against General Motors Company (“GM” or the “Company”) (NYSE: GM) and certain officers. The class action, filed in the United States District …

Distribution channels: Consumer Goods, Law ...
Published on January 26, 2024 - 14:27 GMT

Poland introduces honorary consul office in Đà Nẵng

VIETNAM, January 26 - Poland introduces honorary consul office in Đà Nẵng ĐÀ NẴNG — Poland has officially introduced its honorary consul office in the central city, boosting long traditional friendship ties, culture exchange, investment, trade and …

Distribution channels:
Published on January 26, 2024 - 14:27 GMT

PM inspects combat readiness at Ministry of National Defence

VIETNAM, January 26 - HÀ NỘI — Prime Minister Phạm Minh Chính urged General Department II (General Department for Defence Intelligence) under the Ministry of National Defence to improve its leadership capacity and combat readiness, especially during the Tế …

Distribution channels:
Published on January 26, 2024 - 14:26 GMT

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investments in LivePerson, Inc. of Class Action ...

NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN) and certain officers. The class action, filed in the United States …

Distribution channels: Consumer Goods, Law ...
Published on January 26, 2024 - 14:23 GMT

10 Facts about What FDA Does and Does Not Approve

Español Is It Really "FDA Approved"? Maybe you’ve seen these words on a company’s website or in a commercial promoting a product or treatment. Here are some facts about products that are, and aren’t, FDA approved. Fact #1: Generic medicines work …

Distribution channels: Consumer Goods

Previous 25 26 27 28 29 30 31 32 33 34 35 Next

Previous Day 2024 Calendar Next Day